the medications investigated include: Focalin, Focalin XR (dexmethylphenidate HCl ); Dexedrine, Dexedrine Spansules, Dextroamphetamine ER, Dextrostat (dextroamphetamine sulfate); Vyvanse (lisdexamfetamine dimesylate); Desoxyn (methamphetamine); Concerta, Daytrana, Metadate CD, Metadate ER, Methylin, Methylin ER, Ritalin, Ritalin-LA, Ritalin-SR (methylphenidate); Adderall, Adderall XR (mixed salts amphetamine); Cylert (pemoline) and generics
the research study:
http://ajp.psychiatryonline.org/cgi/reprin...2009.09040472v1
the editorial comment
http://ajp.psychiatryonline.org/cgi/reprin...2009.09050619v1
the FDA comment
http://www.fda.gov/Drugs/DrugSafety/Postma...s/ucm165858.htm
Sheila Rogers also wrote about this in the latest issue of ACN Today Newsletter and linked to this report
http://www.healthfinder.gov/news/new...x?docID=628053